1,721,079 research outputs found

    Opposing roles for specific TIMPs in breast cancer prognostic

    No full text
    The two articles (Span et al. 2004 and Schrohl et al. 2004) highlight the complexity and specificity of matrix metalloproteinases (MMPs) and TIMPs in cancer biology, diagnosis, and treatment. Both provide novel insights into these issues by focussing on TIMPs rather than MMPs and extend a growing number of reports that the roles played by TIMPs in tumour pathology may be much broader than the inhibition of MMP action on the extracellular matrix (ECM), and may extend to the regulation of MMP influence on many systems and potentially to MMPindependent functions. Specific TIMP-3 involvement in tamoxifen-induced apoptosis strongly contrasts the association between elevated TIMP-1 levels with poor outcome in breast cancer. Although candidate apoptotic mechanisms may elegantly explain the effect of TIMP-3 results, the reasons underlying the TIMP-1 result remain to be fully elucidated

    Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

    Get PDF
    Since its original identification as a leukocyte gelatinase/type V collagenase and tumour type IV collagenase, gelatinase B/matrix metalloproteinase (MMP)-9 is now recognised as playing a central role in many aspects of tumour progression. In this review, we relate current concepts concerning the many ways in which gelatinase B/MMP-9 influences tumour biology. Following a brief outline of the gelatinase B/MMP-9 gene and protein, we analyse the role(s) of gelatinase B/MMP-9 in different phases of the tumorigenic process, and compare the importance of gelatinase B/MMP-9 source in the carcinogenic process. What becomes apparent is the importance of inflammatory cell-derived gelatinase B/MMP-9 in tumour promotion, early progression and triggering of the “angiogenic switch”, the integral relationship between inflammatory, stromal and tumour components with respect to gelatinase B/MMP-9 production and activation, and the fundamental role for gelatinase B/MMP-9 in the formation and maintenance of tumour stem cell and metastatic niches. It is also apparent that gelatinase B/MMP-9 plays important tumour suppressing functions, producing endogenous angiogenesis inhibitors, promoting inflammatory anti-tumour activity, and inducing apoptosis. The fundamental roles of gelatinase B/MMP-9 in cancer biology underpins the need for specific therapeutic inhibitors of gelatinase B/MMP-9 function, the use of which must take into account and substitute for tumour-suppressing gelatinase B/MMP-9 activity and also limit inhibition of physiological gelatinase B/MMP-9 function

    BASEMENT-MEMBRANE TYPE-IV COLLAGEN DEGRADATION - EVIDENCE FOR THE INVOLVEMENT OF A PROTEOLYTIC CASCADE INDEPENDENT OF METALLOPROTEINASES

    No full text
    Current hypotheses suggest that both the plasmin system and metalloproteinases are involved in tumor invasion of basement membrane. In this study, we demonstrate that plasmin can directly degrade native and denatured type IV collagen in solution as well as in tissue sections. Tumor cell lines secreted plasminogen activators into culture supernatants that activated exogenous plasminogen to degrade type IV collagen in zymograms and to remove collagen IV immunoreactivity from tissue sections. Inhibition of metalloproteinase activity in culture supernatants by EDTA did not interfere with plasminogen-mediated type IV collagen degrada tion. We propose that tumor cells possess a mechanism for the degra dation of basement membrane type IV collagen, independent of metalloproteinases but dependent on plasminogen conversion to plasmin
    corecore